This service is more advanced with JavaScript available, learn more at http://activatejavascript.org

Reactions Weekly

March 2018, Volume 1695, Issue 1, pp 204–204 | Cite as

Ibrutinib

Decrease in the insulin antibodies and glutamic acid decarboxylase autoantibodies: 2 case reports

Case report

First Online: 31 March 2018

10 Downloads

This is a preview of subscription content, to check access

Reference

Skrabs C, et al. Rapid decline in insulin antibodies and glutamic acid decarboxylase autoantibodies with ibrutinib therapy of chronic lymphocytic leukaemia. Journal of Clinical Pharmacy and Therapeutics 43: 145-149, No. 1, Feb 2018. Available from: URL: http://doi.org/10.1111/jcpt.12602 -AustriaCrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

About this article

Cite this article as:: Reactions Weekly (2018) 1695: 204. https://doi.org/10.1007/s40278-018-44031-1

DOI https://doi.org/10.1007/s40278-018-44031-1
Publisher Name Springer International Publishing
Print ISSN 0114-9954
Online ISSN 1179-2051

Published in cooperation with
Adis

Personalised recommendations